Clinical trial
A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)
NCT04660617 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-omics Study of Metastatic Prostate Cancer (MOSMPCA)
- Lead sponsor
- West China Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2021
- Completion date
- April 1, 2023
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer metastatic